Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial. (Q38060583)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

review article

1 reference

title

Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

main subject

personalized medicine

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Nicolas Servant

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Marc-Henri Stern

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Anne-Gaëlle Le Coroller

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

10

Anne Vincent-Salomon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Maud Kamal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Jean-Pierre Delord

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Mario Campone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Anthony Goncalves

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Nicolas Isambert

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Thierry Conroy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

David Gentien

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Anne-Lise Pouliquen

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sébastien Armanet

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Thomas Rio Frio

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Xavier Paoletti

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Christophe Le Tourneau

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

17 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

253-265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11523-012-0237-6

18 February 2020

exact match

0 references

cites work

Cancer genomics: technology, discovery, and translation

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0237-6

The challenge to bring personalized cancer medicine from clinical trials into routine clinical practice: the case of the Institut Gustave Roussy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0237-6

Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0237-6

Tumour growth kinetics assessment: added value to RECIST in cancer patients treated with molecularly targeted agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0237-6

Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: final results from the EGF104900 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0237-6

Prospective validation of a prognostic score to improve patient selection for oncology phase I trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0237-6

Risks and benefits of phase 1 oncology trials, 1991 through 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0237-6

Cell-free nucleic acids as biomarkers in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0237-6

Considerations in the development of circulating tumor cell technology for clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0237-6

Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0237-6

From theoretical synergy to clinical supra-additive toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0237-6

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0237-6

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11523-012-0237-6

Selecting systemic cancer therapy one patient at a time: is there a role for molecular profiling of individual patients with advanced solid tumors?

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23161020

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Progression-free survival ratio as end point for phase II trials in advanced solid tumors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23161020

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11523-012-0237-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

18 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23161020%20AND%20SRC:MED&resulttype=core&format=json